Aydan Ongun Ozdemir

Aydan Ongun Ozdemir

Auto-generated profile, based on publicly available information

Aydan Ongun Ozdemir

Department of Cardiovascular Medicine, Ankara University School of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2009 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
AOAydan Ongun Ozdemir
Aydan Ongun Ozdemir
CKCANSIN TULUNAY KAYA
CANSIN TULUNAY KAYA
OOOzgur Ulas Ozcan
Ozgur Ulas Ozcan
COCagdas Ozdol
Cagdas Ozdol
BCBasar Candemir
Basar Candemir
CECetin Erol
Cetin Erol

1 September 2005 in The American Journal of Cardiology
Verified
Journal Article
Closed access
YAYusuf Atmaca
Yusuf Atmaca
AOAydan Ongun Ozdemir
Aydan Ongun Ozdemir
COCagdas Ozdol
Cagdas Ozdol
DODidem Oguz
Didem Oguz
SGSadi Gulec
Sadi Gulec
CECetin Erol
Cetin Erol

1 June 2008 in Atherosclerosis
Verified
Journal Article
Closed access
SGSadi Gulec
Sadi Gulec
HKHalil Karabulut
Halil Karabulut
AOAydan Ongun Ozdemir
Aydan Ongun Ozdemir
COCagdas Ozdol
Cagdas Ozdol
STSibel Turhan
Sibel Turhan
ÇEÇetin Erol
Çetin Erol

25 May 2010 in Echocardiography
Verified
Journal Article
Closed access
PDF file
AOAydan Ongun Ozdemir
Aydan Ongun Ozdemir
CKCANSIN TULUNAY KAYA
CANSIN TULUNAY KAYA
COCagdas Ozdol
Cagdas Ozdol
BCBasar Candemir
Basar Candemir
STSibel Turhan
Sibel Turhan
CECetin Erol
Cetin Erol

10 April 2021 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
TTTurkan Seda Tan
Turkan Seda Tan
MAMuge Akbulut
Muge Akbulut
ADAyse Irem Demirtola
Ayse Irem Demirtola
NSNazlı Turan Serifler
Nazlı Turan Serifler
NONil OZYUNCU
Nil OZYUNCU
IDIrem Dincer
Irem Dincer

1 September 2006 in Coronary Artery Disease
Verified
Journal Article
Closed access
IDIrem Dncer
Irem Dncer
AOAydan Ongun
Aydan Ongun
STSibel Turhan
Sibel Turhan
COCagdas Ozdol
Cagdas Ozdol
DKDeniz Kumbasar
Deniz Kumbasar
CECetin Erol
Cetin Erol
The coronary collateral circulation is an alternative source of blood supply to myocardium in the presence of advanced coronary artery disease and the therapeutic promotion of collateral growth appears to be a valuable treatment strategy in these patients. Although it has been shown in in-vivo studies that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) promote vasculogenesis and accelerate coronary collateral development in ischemic tissues, there are discordant results in clinical studies. Our aim was to investigate the effect of statin therapy, including dosage and duration of treatment, on coronary collateral growth in patients with advanced coronary artery disease. Study population consisted of 400 (306 men, with the mean age of 62+/-10 years) consecutive patients who have undergone clinically indicated coronary angiography and had at least one major coronary artery stenosis of > or =95%. Coronary collaterals were graded from 0 to 3 according to the Cohen-Rentrop method and patients with grade 0-1 collateral development were regarded as having poor collateral and patients with grade 2-3 collateral development were regarded as having good collateral. Among 400 patients, 196 (48%) were on statin therapy. Patients with good collateral score were more likely to have stable angina pectoris as clinical presentation (P or =10 mg atorvastatin-equivalent dose had better collateral development (P or =10 mg atorvastatin-equivalent dose [odds ratio 2.06, 95% confidence interval (1.3-2.6), P or =10 mg atorvastatin-equivalent dose), stable angina pectoris and having multivessel disease are associated with enhanced coronary collateral development in patients with advanced coronary artery disease.